Vitruvian Partners LLP Gelesis Holdings, Inc. Call Options Transaction History

Vitruvian Partners LLP

  • $257 Million
  • Q3 2024

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

Others Institutions Holding GLS

# of Institutions
1
Shares Held
4.7K
Call Options Held
0
Put Options Held
0
View Full List

About GELESIS HOLDINGS, INC.

GLS Quotes by TradingView
  • Ticker GLS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 72,946,704
  • Market Cap $1.46M
  • Description
  • Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipelin...
More about GLS
Track This Portfolio

Track Vitruvian Partners LLP Portfolio

Follow Vitruvian Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vitruvian Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Vitruvian Partners LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email